In an effort to understand how the Melligen cells works, can you explain what happens to the pancreas in Type 1 diabetes?

Why are liver cells such good candidates to replace the damaged cells in the pancreas?

What have early lab trials shown?

How does PharmaCyte’s Cell-in-the-Box help the melligen cells do their jobs?

How will this technology help the lives of those patients living with Type 1 Diabetes?

Duration: 15:55

Dr. Gerald Crabtree is PharmaCyte’s Chief Operating Officer. Since 1985, Dr. Crabtree has been involved with various biopharmaceutical companies where he has alternatively supervised and coordinated the development of multiple drug candidates, prepared clinical protocols, investigator brochures, monographs, and research and review articles and served as project manager for development of major oncologic agents. He is a Member of the American Society of Clinical Oncology and also is a past member of research grant review committees for the National Institute of Health and the American Cancer Society. Dr. Crabtree established and directed, from inception, a department that monitored and coordinated the development of oncologic and immunologic drugs from initial discovery through regulatory approval in a major pharmaceutical company and served as project manager for the development of the anticancer agent, Taxol®.

Dr. Crabtree received his Ph.D. in Biochemistry from the University of Alberta, Edmonton, Alberta, Canada and has published over 80 articles in peer-reviewed journals. He is a National Cancer Institute of Canada Research Fellow. In addition, he served as Department Head of Molecular Pharmacology for the Nucleic Acid Research Institute, and prior to that as Associate Professor of Medicine with the Roger Williams Cancer Center at Brown University. Dr. Crabtree has also served as Director of Project Planning and Management (Oncology/Immunology) at Bristol-Myers Squibb and as Vice-President of Research and Development at ETEX Corporation.

Christian Drapeau, Co-Founder & Chief Science Officer of Stemtech International, a leader in the field of stem cell nutrition, and Author of "Cracking the Stem Cell Code" joins eHealth Radio and the General Health and News Channels to discuss his innovative research & development of Stemtech's all natural, stem cell nutrition products.

What is stem cell nutrition? And how can we enhance our own stem cells?

You are the co-founder and Chief Science Officer at Stemtech International, a pioneer in the field of stem cell nutrition. Can you tell our listeners about Stemtech's nutritional products?

Can anyone take Stemtech's all natural nutritional products?

Stemtech also developed DermaStem Renewal Serum. How does DermaStem work to rejuevenate the skin and reduce signs of premature aging?

Stemtech's SE2 is the world's first all natural supplement documented to support the release of adult stem cells. SE3 is being launched in June. Can you tell us about this new innovative addition to Stemtech's products?

Stemcell medicine & therapy has shown great potential for pets. How does stem cell nutrition help to maintain our pets health? Can you tell us about StemPets and StemEquine?

Duration: 18:16

Christian Drapeau, MSc Stemtech International, Chief Science Officer

Research scientist and neurophysiologist Christian Drapeau has more than 15 years of research experience in the fields of natural foods and nutrition. Christian has collaborated with several universities and research centers in researching raw botanical ingredients and serves as Chief Science Officer for Stemtech International.

What is your recommendation to patients who choose facial procedures based on short recovery times?

What common misconceptions do you find patients have during your consult with them for a facial procedure?

What are the benefits of a mini facelift or a facelift?

After getting a surgical facial procedure, what are your general recommendations to maintain their new look and prolong results?

As a surgeon, what important questions should patients be asking during their consultation?

Duration: 15:03

Dr. James R. Shire has combined a lifelong interest in the arts with a career in medicine in his practice of facial plastic surgery. Dr. Shire is Board Certified by the American Board of Facial Plastic and Reconstructive Surgeons, The American Board of Otolaryngology Head and Neck Surgeons, and is a Fellow of the American College of Surgeons. Dr. Shire was also the Director of Facial Plastic Surgery at the Albert Einstein College of Medicine from 1995-1998.

After shifting to Chattanooga, TN, Dr. Shire quickly become the premier facial cosmetic surgeon in the area, and still holds a large following among out of state patients - seeking his unparalleled artistry, expertise and patient satisfaction. In addition to his thriving practice, Dr. Shire has dedicated his career to expanding the field of facial plastic surgery. He has contributed his expertise and excellence by co-authoring over 10 medical textbooks providing cutting edge techniques for various facial rejuvenation procedures. Some of these topics include, Facelifing Incisions, Rhinology, Prejowl Implants, Facial Implants and lastly Deep Chemical Peeling which is set to release in the fall of 2015.

Dr. Shire organized and co-directed the Faces of Jerusalem in 2010 and was invited to the International German Symposium for Plastic – Reconstructive Surgery in 2012. Later that year, Dr. Shire conducted an instructional course on ‘The Modified Phenol-Croton Oil Peel’ in Washington D.C. and again later conducted the same course in New Orleans the following year.

Dr. Shire has been voted the best Plastic Surgeon in the Chattanooga area for the last six years and is listed in ‘Best Doctors in America’. He has been known as Consumers’ Research Council of America’s Top Surgeons – voted in every year since 2005.

Dr. Daniel Twogood a Chiropractor who has been practicing in Apple Valley, California for over 30 years and the author of his 4th book, Chronic Pain Gone 90 Days joins eHealth Radio and the Health News and Pain Management Channels.

Your book is called Chronic Pain Gone 90 Days. Is that realistic? Can a person recover from chronic pain in just 90 days?

So what does cause chronic pain?

So why is the body failing to heal?

So does that mean chronic pain sufferers need to change their diets? Should people eat a vegan diet, or eat organic food?

What are some of those things that cause chronic pain?

Aren’t dairy foods supposed to be good for you, like for strong bones?

Are there some non-dairy substitutes that people can use instead?

That’s depressing because lots of people love chocolate. What about dark chocolate?

So if patients avoid the pro-inflammatory things that cause inflammation, how long does it take to feel a difference?

What about soy cheese?

Are there other substances that can cause inflammation?

Duration: 17:46

Dr. Daniel Twogood is a chiropractor from Apple Valley, California. He graduated from the University of California at Santa Barbara with a degree in Physical Education in 1973, and graduated magna cum laude from Cleveland Chiropractic College in Los Angeles in 1983. He began practicing at The International Sports Medicine Institute in West Los Angeles where he treated many of the athletes in the 1984 Los Angeles Olympics. He opened his own practice in Apple Valley, California in 1985 where hew discovered the diet/pain connection. He has written four books on Chronic Pain: the latest is Chronic Pain Gone 90 Days.

Fellowship Trained Eye Plastic Surgeon and Board Certified Ophthalmologist Dr. Deborah Sherman, who has the highest level of training in plastic surgery around the eyes joins eHealth Radio and the Plastic Surgery Information Channel.

What is the most important thing you tell your patients about getting BOTOX treatments?

What other issues can BOTOX resolve?

Duration: 17:39

Located in Nashville, Tennessee, Dr. Sherman has been performing eyelid surgery for over twenty years. She is recognized as a top plastic surgeon for eyes and is often invited to teach her innovative approaches to her colleagues at national meetings. She has also been invited overseas to teach these advanced cosmetic techniques to surgeons throughout Russia and China.

Dr. Sherman received her specialty training by top surgeons associated with the Department of Ophthalmology at Vanderbilt University School of Medicine. She further advanced her training in cosmetic surgery techniques during her Oculoplastics fellowship at the University of Wisconsin in Madison, Wisconsin. There, she studied under the direction of Richard K. Dortzbach MD, a former President of ASOPRS, American Society of Ophthalmic, Plastic & Reconstructive Surgery (Oculofacial Plastic Surgery).

Dr. Sherman is a fellow of the American Society of Ophthalmic, Plastic & Reconstructive Surgery (Oculofacial Plastic Surgery) which requires completion of a clinical fellowship, original research, and written and oral Board Examinations.

Dr. Sherman has served as the Botox® national spokesperson for their “Lose Your 11” Campaign, during which she taught “beauty buzzmakers” in educational seminars in over thirty US cities. She has been a guest on multiple local and national television and radio shows and has written many articles that have been published in peer-reviewed journals. She teaches colleagues and future surgeons all over the world about cosmetic techniques for use specifically in plastic surgery around the eyes. Dr. Sherman and her staff offer educational seminars about the various cosmetic treatments available.

What are the dangers of poor indoor air quality and why should people be concerned about it?

What are some things homeowners can do to improve their home's indoor air quality?

How does Air Scrubber Plus work?

What other health benefits do users of Air Scrubber Plus report?

What is the connection between Air Scrubber Plus and NASA technology?

Duration: 11:47

Tom Lozano is executive director of Air Scrubber Plus®, a revolutionary indoor air quality system that launched nationally in the fall of 2013. Tom Lozano joined the Air Scrubber Plus® sales and marketing team in 2008 and has been actively involved in all relevant areas of the consumer indoor air quality marketplace since 1996.

The improvement of indoor air quality has been a personal mission of Tom Lozano's as a result of his own struggle with severe allergies. After installing the Air Scrubber Plus® system in his own home, Tom experienced life-changing relief from his debilitating allergy symptoms. The dramatic change prompted Tom Lozano to approach the manufacturers of Air Scrubber Plus®, and eventually he, and his business partner Allen Brasington, took over national and international sales and marketing to heating and cooling contractors and millions of consumers searching for cleaner air for their family.

During his tenure with Air Scrubber Plus®, Tom Lozano has helped Air Scrubber Plus realize double-digit growth. Tom Lozano's main goals are broad: to move the heating and cooling industry's technology forward through education and training. By bringing the breakthrough technology of Air Scrubber Plus® to the consumer/homeowner market, Tom Lozano aims for every home to enjoy the benefits of clean air without harsh chemicals or ineffective filter systems.

Tom Lozano earned a bachelor of arts degree in philosophy and religion from San Francisco State University in 1976. In 1996, he earned a theological degree from Bethel Theological Seminary in San Diego.

Tell us a little bit about how you came up with the name Crazy Richard’s? Who is Crazy Richard’s?

There are a lot of peanut butters out there, what makes Crazy Richard’s Peanut Butter different and unique?

What’s new with Crazy Richard’s? I heard about this powdered peanut butter, tell us more about it, especially its applications.

What about the new PB Burst that, I was told, caters to people who are leading a very active lifestyle?

Please tell us where and what stores they can buy it from?

Where can we reach you online and in social media?

Duration: 9:33

The daughter of Crazy Richard, Kimberly holds an Associate’s Degree from BYU-Idaho in photography and received a Bachelor of Fine Arts in Art History and Curatorial Studies. A mother of 4, Kimberly leads an active lifestyle working as the spokesperson for Crazy Richard’s Peanut Butter Company and working with youth at her local church.

Tell us about your pioneering work in personalized chemotherapy and functional profiling.

Is it possible to choose the most effective chemotherapy drugs before patients receive them?

Why hasn’t this been more widely applied?

Do you have published data to support your work?

What do you think has made it possible for you to succeed where others have failed?

Going forward, what are the implications of your ability to successfully conduct these studies?

What is the best advice you can give to people who have been just diagnosed with cancer?

Duration: 10:24

Robert A. Nagourney, MD, is Medical and Laboratory Director at Rational Therapeutics, Inc., in Long Beach, California, and a Clinical Professor, University of California Irvine, Department of Obstetrics and Gynecology. He is board certified in internal medicine, medical oncology, and hematology.

A native of Bridgeport, Connecticut, Dr. Nagourney completed undergraduate education at Boston University, earning a BA in Chemistry, Summa Cum Laude, Phi Beta Kappa with Distinction in Biochemistry. He received his MD at McGill University in Montreal, Canada, where he was a University Scholar. After completing his residency in Internal Medicine at the University of California, Irvine, Dr. Nagourney received fellowship training in Medical Oncology at Georgetown University in Washington, DC. He went on to complete a second fellowship in hematology at the Scripps Institute in La Jolla, California, where he was the recipient of the Scripps Institute Young Investigator Award.

Dr. Nagourney went on to found Rational Therapeutics, a cancer research institute located in Long Beach, California, that has pioneered the development of “functional profiling” in human tumors. The functional profiling platform uses human tumor microspheroids in primary culture to measure drug induced programmed cell death, both apoptotic and non-apoptotic. It has proven a robust method for the prediction of clinical response to therapy. Following its successful application to cytotoxic drugs and radiation, this platform has now been successfully applied in the development of novel compounds, drug combinations and to the study of signal transduction inhibitors and “targeted” agents.

With over 20 years experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts, book chapters and abstracts including publications in the Journal of Clinical Oncology, Gynecological Oncology and The Journal of National Cancer Institute. As co-investigator on national cooperative trials, Dr. Nagourney is recognized for the introduction of Platin/Gemcitabine doublets to the treatment of advanced ovarian and breast cancer. A frequently invited lecturer for numerous professional organizations and universities, Dr. Nagourney has served as a reviewer and on the editorial boards of several journals including Clinical Cancer Research, British Journal of Cancer, Gynecologic Oncology, Cancer Research and the Journal of Medicinal Food. Dr Nagourney resides in Long Beach, California with his wife and two sons.

Christopher Henze, Director of the new breakthrough documentary, Big Belli presents "40 Weeks" & Dominique Debroux the CEO of Big Belli and a Co-Producer of "40 Weeks" the movie joins eHealth Radio and the Female Health and Pregnancy Channels.

What is "40 Weeks" the movie? How does it differ from other movies on pregnancy?

In addition to very personal interviews with the 13 women, who else is featured in the movie?

What do you hope to accomplish with the release of "40 Weeks" the movie?

How does the movie fit in with the new website BigBelli.com?

What are the future plans or projects from BigBelli?

Duration: 8:56

Christopher Henze, Director "40 Weeks" the movie, also directed over 100 commercials, including Andrea Bocelli's "Amore", award nominated music videos and industrials. He is the proud father of Gaia who served as the inspiration for "40 Weeks" and "One".

Dominique Debroux, Big Belli CEO and co-producer of "40 Weeks" and "One". She has 15 years experience establishing and managing US divisions for European companies. Past positions included VP Rosa Clara USA; GM LILITH, USA and GM Thierry Mugler. She also produced the Cannes premiered "The Shade".

Align Footwear’s Co-founders, Chris Buck and Physical Therapist, Cheryl Kosta join eHealth Radio and the Foot Health and News Channels to discuss the Portland based startup, that is redefining the insole experience with their breakthrough insoles, Arch Mobility.

Entrepreneur, Chris Buck, partnered up with physical therapist, Cheryl Kosta and created an insole that takes a different approach in preventing foot pain and fatigue; using Align Tri-planar Technology, a revolutionary design that aligns the kinetic chain by utilization of Tri-planar control, which focuses on aligning the foot, and the entire body, from bottom to top. After years of studying with footwear industry veterans, Buck and Kosta, former personal physical therapist to Olympic skier, Picabo Street and NBA power-forward, Kevin Love, launched Arch Mobility insoles in March 2014.

A third-party study, conducted by Martyn Shorten PhD, of BioMechanica, LLC., showed that Arch Mobility insoles align the ankle 32% more, decrease pronation 27% more, and align the tibia (shin) 40% more, than any other insole in the market today.

Arch Mobility currently offers a single insole for everyday wear. In June, Arch Mobility will introduce a new product featuring technology similar to the type the military uses to absorb impact from IED explosions. Upcoming additions include a three-quarter-length insole and a high heel version. The company is expanding into retail stores this year.